New transcriptional-based insights into the pathogenesis of desmoplastic small round cell tumors (DSRCTs). by Negri, T et al.
Oncotarget1www.impactjournals.com/oncotarget
www.impactjournals.com/oncotarget/ Oncotarget, Supplementary Material
New transcriptional-based insights into the pathogenesis of 
desmoplastic small round cell tumors (DSRCTs)
Supplementary Material
SUPPLEMENTARY METHODS 
IHC: antibodies and conditions. 
P-cadherin (#2130s, Cell Signaling Technology, 1:50, extended CC1 buffer, optiview DAB); E-cadherin (M3612, 
Dako, 1:50, extended CC1 buffer, optiview DAB); SLUG (#9585s, Cell Signaling Technology, 1:50, extended CC1 buffer, 
optiview DAB); ZEB-1 (HPA027524, Sigma, 1:200, standard CC1 buffer, ultraview DAB); CD163 (NCL-CD163, Leica, 
1:100, standard CC1 buffer, ultraview DAB); PD-L1 (SP-140, Roche, 1:50, CC1 buffer, optiview DAB) were performed using 
Ventana Benchmark ULTRA platform. 
Desmin (IR606, Dako, 1:400, high 15’ EDTA 15’ linker mouse); CD3 (IS503, Dako, 1:400, high 15’ EDTA 15’ linker 
rabbit); CD20 (IR604, Dako, 1:400, high 15’ EDTA 15’ linker mouse); AR (M3562, Dako, 1:25, high 15’ EDTA 15’ linker 
mouse); β-catenin (610154, BD transduction, 1:1000, high 30’ EDTA 15’ linker mouse); PDGFRA (sc-338, Santa Cruz 
Biotechnology, 1:200, high 15’ EDTA 15’ linker rabbit), were performed using Dako Autostainer Link 48. 
CD14 (MS-1080, Thermofisher, 1:10) was performed using a pressure cooker heating Dako, 110°C, 20’EDTA buffer, 
4°C overnight incubation. 
miRNA in situ hybridisation (ISH) evaluation 
The positive staining signals for miRNAs were identified as brown dots usually localised in the cytoplasm. The size 
and intensity of the dots varied from case to case, and also depended on the miRNA. miRNA expression in tumor cells was 
evaluated using a 1-16 scoring system in which the percentage of positive cells (1 = <25%; 2 = 25-50%; 3 = 50-75%; 4 = 75-
100%) was multiplied by the number of signals per cell (1 = 1-3 dots; 2 = 4-6 dots; 3 = 6-9 dots;4 = >10 dots). 
ISLR/Meflin mRNA ISH 
For each case a negative control probe (bacterial gene 4-hydroxy-tetrahydrodipicolinate reductase [DapB] #310043, 
Advanced Cell Diagnostics) and a positive control probe for evidence of preserved RNA (housekeeping gene ubiquitin C 
[UbC] #310041, Advanced Cell Diagnostics) was included. ISH was performed manually using the RNAscope 2.5 High 
Definition detection kit 12 (brown) (Advanced Cell Diagnostics, Inc., Hayward, CA) in accordance with the manufacturer’s 
instructions.  Briefly, 5 μm FFPE tissue sections were incubated with hydrogen peroxide for 10 minutes at room temperature 
(RT). The slides then were boiled in Target Retrieval 1X buffer for 45 minutes, followed by incubation with Protease Plus for 
30 minutes at 40°C, and then hybridised with the relevant probes for two hours at 40°C, followed by successive incubations 
with Amp1-Amp6 reagents, colour development with 3,3’-diaminobenzine (DAB), and counterstaining with hemotoxylin. 
The positive control was a gastrointestinal stromal tumor (GIST) with a high level of PDGFRA mRNA expression. Positive 
staining signals were identified as brown, punctuate dots in the cytoplasm and/or nucleus. 
ISRL/Meflin mRNA ISH scoring 
ISRL/Meflin mRNA was analysed by using a scoring system that categorised the cases into five grades depending on 
the number of dots visualised under a bright-field microscope: 0 = no staining or <1 dot every 10 cells; 1+: 1-3 dots/cell; 2+: 
4-10 dots/cell with very few dot clusters; 3+: >10 dots/cell with <10% of positive cells having dot clusters; and 4+: >10 dots/
cell with >10% of positive cells having dot clusters.
For Supplementary Tables 1-6 see in Supplementary Files.
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Supplementary Figure 1: Small CD3-positive and a less extensive PD-L1 immunolabelled area from the surgical 
sample of DSRCT 2 case.
Supplementary Figure 2: AR and β-catenin IHC in DSRCT 4 (A), DSRCT 2 (B) and DSRCT 6 (C) cases. Nuclear AR 
and membrane β-catenin immunostaining on consecutive sections revealed two superimposable patterns of decoration in the two cases 
belonging to group 1 (A and B ) and one belonging to group 2 (C).
Supplementary table 1. Differentially expressed genes by class comparison 






ILMN_1769129 NM_006274 CCL19 6363 6 0,0001469 0,043 
ILMN_1727605 NM_002031 FRK 2444 2,92 0,0002724 0,043 
ILMN_2395981 NM_152501 PYHIN1 149628 5,35 0,0003966 0,043 
ILMN_1680339 NM_006207 PDGFRL 5157 3,96 0,0003986 0,043 
ILMN_2261627 NM_005214 CTLA4 1493 5,27 0,0004188 0,043 
ILMN_1746085 NM_000598 IGFBP3 3486 2,94 0,0004351 0,043 
ILMN_1815093 NM_001005325 OR6M1 390261 3,96 0,0004416 0,043 
ILMN_1707591 NM_024873 TNIP3 79931 5,65 0,0006432 0,043 
ILMN_1774982 NM_145057 CDC42EP5 148170 3,87 0,0007672 0,043 
ILMN_1740385 NM_014956 CEP164 22897 0,15 0,0008565 0,043 
ILMN_2366212 NM_001039933 CD79B 974 5,25 0,0008729 0,043 
ILMN_1761858 NM_033290 MID1 4281 3,55 0,000879 0,065 
ILMN_1779324 NM_006144 GZMA 3001 5,12 0,0009386 0,065 
ILMN_1802611 NM_015001 SPEN 23013 0,26 0,0011817 0,07 
ILMN_1733276 NM_006639 CYSLTR1 10800 4,21 0,0013226 0,07 
ILMN_2044081 NM_001040704 DEFB106B 503841 3,23 0,0013304 0,07 
ILMN_1792538 NM_006137 CD7 924 6,43 0,0014039 0,07 
ILMN_1786278 NM_015398 FAM149A  25854 2,72 0,0014324 0,07 
ILMN_2342579 NM_002185 IL7R 3575 2,79 0,001466 0,07 
ILMN_1720440 NM_133636 HELQ 113510 0,35 0,0015722 0,07 
ILMN_2088124 NM_152680 TMEM154 201799 3,64 0,0016151 0,07 
ILMN_1683757 NM_020982 CLDN9 9080 5,52 0,0018897 0,07 
ILMN_1784774 NM_014499 P2RY10 27334 4,13 0,0019972 0,07 
ILMN_3237069 NM_001100817 TCEB3CL 728929 5,86 0,0021081 0,07 
ILMN_2231928 NM_002463 MX2 4600 4,87 0,0021538 0,07 
ILMN_2349658 NM_007311 TSPO 706 2,78 0,0021881 0,07 
ILMN_2125747 NR_002454 LOC606724 606724 4,53 0,0022093 0,07 
ILMN_1675191 NM_152687 GAPT 202309 3,55 0,0022844 0,07 
ILMN_1727532 NM_020190 OLFML3 56944 3,06 0,0023046 0,07 
ILMN_2111229 NM_004758 BZRAP1 9256 0,31 0,002321 0,07 
ILMN_1760208 NM_024034 GDAP1L1 78997 3,7 0,0023766 0,07 
ILMN_2068257 NM_032348 MXRA8 54587 3,63 0,0025907 0,07 
ILMN_1651692 NM_005990 STK10 6793 3,07 0,0026514 0,11 
ILMN_1763442 NM_020717 KIAA1202 57477 0,37 0,0026632 0,11 
ILMN_1723962 NM_020169 LXN 56925 3,03 0,0026688 0,11 
ILMN_1777949 NM_173080 SPRR4 163778 5,7 0,0026985 0,11 
ILMN_1805098 NM_000924 PDE1B 5153 3,13 0,0027508 0,11 
ILMN_1773352 NM_002985 CCL5 6352 7,02 0,0028832 0,11 
ILMN_1781951 NM_014191 SCN8A 6334 0,36 0,0028929 0,11 
ILMN_1712628 NM_016328 GTF2IRD1 9569 0,34 0,0029183 0,11 
ILMN_1668910 NM_014430 CIDEB 27141 2,78 0,0029764 0,11 
ILMN_1804901 NM_173170 IL1F5 26525 6,12 0,0031604 0,11 
ILMN_1663683 NM_014799 HEPH 9843 4,04 0,0031826 0,11 
ILMN_2354381 NM_000305 PON2 5445 0,24 0,0033782 0,11 
ILMN_1738725 NM_002309 LIF 3976 3,54 0,003396 0,11 
ILMN_2368530 NM_001012633 IL32 9235 6,3 0,0033997 0,11 
ILMN_1678517 NM_016234 ACSL5 51703 3,96 0,003456 0,11 
ILMN_1739397 NM_053274 GLMN 11146 0,34 0,0034638 0,11 
ILMN_1682332 NM_016815 GYPC 2995 5,76 0,0034808 0,11 
ILMN_1663866 NM_000358 TGFBI 7045 4,19 0,0035307 0,11 
ILMN_3246071 NM_001130405 PRR20C 729240 11,79 0,0036474 0,11 
ILMN_1758728 NM_004629 FANCG 2189 0,33 0,0037044 0,11 
ILMN_1770433 NM_002649 PIK3CG 5294 2,77 0,003717 0,11 
ILMN_1747593 NM_005545 ISLR 3671 4,78 0,0037228 0,11 
ILMN_1664543 NM_001031683 IFIT3 3437 2,99 0,0037384 0,11 
ILMN_1779257 NM_001250 CD40 958 4,13 0,0038034 0,11 
ILMN_1759175 NM_007207 DUSP10 11221 3,11 0,0038608 0,12 
ILMN_1692332 NM_001139 ALOX12B 242 5,44 0,0038826 0,12 
ILMN_1667232 NM_014511 KIR2DL3 3804 4,17 0,0039639 0,12 
ILMN_1778064 NM_007076 FICD 11153 2,93 0,0039788 0,12 
ILMN_1758315 NM_173653 SLC9A9 285195 2,94 0,0039906 0,12 
ILMN_1665647 NM_005582 CD180 4064 3,14 0,0040801 0,12 
ILMN_1781721 NM_022779 DDX31 64794 0,3 0,0041651 0,12 
ILMN_2083588 NM_001008237 TTC32 130502 0,32 0,0042039 0,12 
ILMN_3245098 NR_002838 KC6 641516 4,53 0,0042277 0,12 
ILMN_1691743 NM_152219 GJD3 125111 2,76 0,0043072 0,12 
ILMN_1762115 NM_145858 CRYZL1 9946 0,29 0,0043225 0,12 
ILMN_1763311 NM_030572 C12orf39 80763 0,3 0,0043272 0,12 
ILMN_1732023 NM_001098173 PRDM7 11105 3,29 0,0043686 0,12 
ILMN_1713749 NM_007074 CORO1A 11151 6,13 0,0044492 0,12 
ILMN_1766169 NM_005504 BCAT1 586 4,62 0,004458 0,12 
ILMN_1713347 NM_006614 CHL1 10752 3,21 0,0044958 0,12 
ILMN_1703708 NM_001012710 KRTAP5-10 387273 2,87 0,0045719 0,12 
ILMN_1712506 NM_130797 DPP6 1804 0,26 0,0045758 0,12 
ILMN_1753789 NM_022093 TNN 63923 5,81 0,004715 0,12 
ILMN_1716563 NM_212535 PRKCB1 5579 3,1 0,0049304 0,12 
ILMN_2138622 NM_207495 DKFZp686I15217 401232 2,82 0,0049442 0,12 
 
Supplementary table 2. IHC assessment of 
the immune system biomarkers 
Patient ID CD3 CD20 CD14 CD163 
DSRCT 1 - - - - 
DSRCT  2 + - + + 
DSRCT 3 - - - - 
DSRCT 4 - - + + 
DSRCT 5  - - - - 
DSRCT 6 - - + + 
DSRCT 7 - - - - 
 
 
Supplementary table 3. Chimera module-based subdivision. a 
patient ID   miR-200 
E-
cadherin 





DSRCT 4 Group 
1 
(MErT) 
high +++ - high + foc + 2 
DSRCT 2 high ++ - high + ++het ++ → - 1 
  




int ++ het ++ het int + +++ foc 2 
DSRCT 6 int ++het ++ het int + ++het ++ 2 





low - ++ low + +++ +dot 1 
DSRCT 7 low - +++ low - ++het - 2 
          a) the last column indicates GEP clusters subdivision 
int: intermediate; het: heterogeneous; foc: focal 
 












DSRCT 1   ♂ /17  DAPD epirubicin/ifosfamide(6) 4 lost 
DSRCT  2  ♂ / 32 DAPD epirubicin/ifosfamide/ etoposide/CDDP (3) 3 
AWD (48)  
lost 
DSRCT 3   ♂ /  32 DAPD epirubicin/ifosfamide/ etoposide/CDDP (4) 3 DOD (36) 
DSRCT 4   ♂ /  32 DAPD epirubicin/ifosfamide/ etoposide/vincristine (3) 4 DOD (11) 
DSRCT 5    ♂ /  19 DAPD epirubicin/ifosfamide/ etoposide/CDDP (3) 4 AWD (8) lost 
DSRCT 6   ♂ /  28  DAPD, M1a epirubicin/ifosfamide/ etoposide/CDDP (6) 4 
AWD (20) 
lost 
DSRCT 7   ♂ /  24 DAPD epirubicin/ifosfamide/ etoposide/vincristine (4) 3 DOD (60) 
a) M1: synchronous lung metastasis 
   DAPD:  diffuse abdominopelvic disease; AWD: alive with disease; DOD: dead of disease 
  
Supplementary table 6. Human cancer stem cell RT2 profiler PCR array raw data 
  Glioblastoma DSRCT 5 DSRCT 1 DSRCT 4 DSRCT 7 
ABCB5 A1 31,93 32,31 32,54 25,10 31,34 
ABCG2 A2 24,96 27,44 27,64 23,68 27,57 
ALCAM A3 24,70 25,62 26,34 21,04 28,20 
ALDH1A1 A4 29,07 27,90 27,49 24,35 30,97 
ATM A5 25,33 25,70 26,56 23,75 26,72 
ATXN1 A6 25,14 26,46 27,54 24,23 30,03 
AXL A7 24,75 22,88 22,38 21,23 22,62 
BM1 A8 28,17 28,64 30,91 23,83 29,48 
BMP7 A9 26,76 24,91 25,90 21,95 27,64 
CD24 A10 31,57 27,73 25,60 24,32 28,45 
CD34 A11 24,00 26,90 26,47 24,04 26,44 
CD38 A12 Undetermined 31,19 30,64 28,22 Undetermined 
CD44 B1 26,28 28,91 29,41 24,83 31,78 
CHEK1 B2 25,19 25,81 27,69 25,95 27,83 
DACH1 B3 32,09 Undetermined 31,96 27,14 33,21 
DDR1 B4 28,12 30,81 30,90 25,38 38,20 
DKK1 B5 32,52 32,06 31,60 28,28 32,06 
DLL1 B6 31,72 Undetermined Undetermined 24,11 Undetermined 
DLL4 B7 32,64 30,68 30,85 25,14 33,04 
DNMT1 B8 25,20 26,37 25,95 23,56 28,55 
EGF B9 29,48 36,38 36,82 27,35 Undetermined 
ENG B10 27,45 32,97 29,65 25,78 32,46 
EPCAM B11 31,89 25,24 25,79 21,91 29,04 
ERB2 B12 33,82 32,46 26,95 22,36 29,67 
ETFA C1 23,57 23,61 24,69 22,00 24,81 
FGFR2 C2 27,67 28,16 28,97 23,92 28,40 
FLOT2 C3 26,74 28,25 28,32 22,82 29,73 
FOXA2 C4 36,33 27,83 28,74 24,30 30,89 
FOXP1 C5 24,87 23,54 23,79 20,51 25,73 
FZD7 C6 25,52 24,29 25,28 21,98 24,70 
GATA3 C7 Undetermined 36,94 Undetermined 29,24 Undetermined 
GSK3B C8 26,71 29,18 28,83 23,76 30,55 
HDAC1 C9 24,37 23,89 24,17 20,83 24,65 
ID1 C10 27,21 29,43 31,43 28,11 34,82 
IKBKB C11 25,85 26,73 26,19 21,81 28,91 
IL8 C12 27,31 29,84 28,40 25,50 33,58 
ITGA2 D1 27,31 26,89 28,28 24,67 27,65 
ITGA4 D2 27,34 29,08 27,61 26,53 30,82 
ITGA6 D3 26,33 27,11 25,37 23,19 26,44 
ITGB1 D4 29,26 30,55 30,83 25,64 31,60 
Jag1 D5 22,66 25,10 24,85 20,96 Undetermined 
Jak2 D6 27,41 27,58 27,65 25,50 28,03 
KIT D7 33,24 32,87 Undetermined 31,02 Undetermined 
KITlig D8 26,87 29,91 29,30 25,79 30,71 
KLF17 D9 33,94 34,17 Undetermined 28,51 33,15 
KLF4 D10 28,81 33,63 30,80 25,11 33,52 
Lats1 D11 29,54 29,51 31,76 25,28 33,81 
Lin28A D12 29,71 30,63 31,56 27,81 Undetermined 
Lin28B E1 Undetermined 32,69 34,35 25,20 30,53 
Maml1 E2 26,87 26,53 30,38 22,27 29,09 
MERTK E3 29,75 27,24 28,24 22,64 29,28 
MS4A1 E4 34,64 32,77 34,51 30,75 34,90 
Muc1 E5 30,42 28,66 29,59 25,39 31,87 
Myc E6 22,89 25,39 26,82 21,77 26,36 
MycN E7 28,23 33,70 32,68 30,47 34,40 
Nanog E8 31,91 26,87 28,88 24,47 30,67 
NFKB1 E9 29,27 29,34 30,19 26,18 33,43 
Nos2 E10 26,48 33,21 31,24 27,46 Undetermined 
Notch1 E11 29,89 31,85 31,36 26,88 35,74 
Notch2 E12 23,94 25,31 25,64 21,59 25,35 
Pecam1 F1 Undetermined 36,91 36,55 33,02 36,27 
Plat F2 36,35 Undetermined 37,43 38,03 36,82 
Plaur F3 26,74 25,62 25,51 21,43 27,88 
Pousf1 F4 29,82 30,30 31,21 26,28 32,68 
Prom1 F5 26,64 30,56 31,50 31,70 Undetermined 
PTCH1 F6 33,35 34,45 Undetermined 28,79 Undetermined 
PTPRC F7 30,29 31,31 34,57 28,84 34,63 
sav1 F8 29,60 28,64 29,04 24,39 30,11 
Sirt1 F9 27,54 26,61 27,32 23,63 27,43 
Smo F10 28,23 28,45 28,14 23,72 29,43 
Snail1 F11 35,00 36,13 Undetermined 33,94 Undetermined 
Sox2 F12 24,87 27,75 28,61 24,46 30,15 
Stat3 G1 26,71 27,30 26,89 22,48 28,27 
TAZ G2 27,47 27,72 27,77 23,15 30,79 
TGFBR1 G3 24,18 25,63 24,47 22,26 25,65 
THy1 G4 27,04 30,21 28,19 26,90 31,01 
Twist1 G5 32,04 Undetermined 33,58 27,26 37,39 
Twist2 G6 36,98 Undetermined Undetermined 36,43 38,46 
WEE1 G7 27,63 28,18 29,17 24,51 30,06 
WNT1 G8 32,54 32,14 Undetermined 29,70 32,87 
WWC1 G9 32,76 33,99 35,04 30,01 34,30 
Yap G10 27,43 27,53 29,00 22,91 33,43 
ZEB1 G11 23,02 26,44 26,44 22,94 25,38 
ZEB2 G12 26,27 28,16 28,27 24,50 28,35 
Actina B H1 26,32 27,42 27,19 21,61 29,37 
B2M H2 22,53 23,95 24,29 21,28 25,64 
GAPDH H3 22,85 27,47 27,54 22,81 29,36 
HPRT H4 26,57 27,37 27,04 25,59 28,52 
RPLP0 H5 23,96 25,17 26,26 22,12 28,10 
HGDC H6 31,35 Undetermined Undetermined 34,32 32,89 
RTC H7 19,48 19,73 18,90 19,32 18,78 
RTC H8 19,56 19,89 19,16 19,40 18,87 
RTC H9 19,45 19,64 18,97 19,88 18,66 
PPC H10 17,91 18,65 18,28 18,57 18,30 
PPC H11 17,82 18,83 18,57 18,57 18,39 
PPC H12 19,59 19,16 19,24 19,35 18,64 
 
